A quantitative comparison of RhoA and RhoB expression in psoriasis - 10/08/11
Seung-Phil Hong, MD, PhD, Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Chong Hyun Won, MD, PhD, Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Hana Bak, MD, PhD, Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Jeong Eun Kim, MD, Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Sik Haw, MD, Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
Le texte complet de cet article est disponible en PDF.| Commercial support: None identified. |
Vol 64 - N° 2S1
P. AB152 - février 2011 Retour au numéro
Article précédent
- The efficacy of retreatment with adalimumab in moderate to severe psoriasis following treatment interruption after 33 weeks or >3 years of 40 mg every other week dosing
- Adalimumab treatment of psoriasis patients following suboptimal responses to etanercept, methotrexate, or phototherapy: Efficacy across subgroups in an open-label study
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?